OSUMI, H., SHINOZAKI, E., OSAKO, M., KAWAZOE, Y., OBA, M., MISAKA, T., . . . MIZUNUMA, N. (2015). Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival. Mol Clin Oncol.
Citação norma ChicagoOSUMI, HIROKI, et al. "Cetuximab Treatment for Metastatic Colorectal Cancer With KRAS P.G13D Mutations Improves Progression-free Survival." Mol Clin Oncol 2015.
MLA citiranjeOSUMI, HIROKI, et al. "Cetuximab Treatment for Metastatic Colorectal Cancer With KRAS P.G13D Mutations Improves Progression-free Survival." Mol Clin Oncol 2015.
Opozorilo: Ti citati niso vedno 100% točni.